- Eric Terry | April 16, 2012 11:26 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
After studies reported as high as a threefold increase in the risk of blood clots for Yaz and similar products, the FDA has ordered Yaz, Yasmin, Beyaz, Safyral, and some generics to change their...
- Eric Terry | March 21, 2012 10:40 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
The original controversy surrounding the FDA’s advisory panel on the benefits and risks of Yaz and Yasmin birth control pills focused on the professional conflicts of interests of the panel...
- Eric Terry | January 12, 2012 11:58 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
The British Medical Journal (BMJ) reports that at least four members of a recent special safety committee advising the US Food and Drug Administration on the safety of drospirenone had financial...
- Eric Terry | November 04, 2011 10:49 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Although it is still one of the highest selling birth control pills on the market, Bayer’s blockbuster birth control pill, Yasmin or Yaz (hereinafter “Yaz”), has been under...
- Jamie G. Goldstein | July 06, 2011 2:31 PM | Chicago, IL
Category:
FDA & Prescription Drugs
Yaz, Yasmin, Ocella, were supposed to give women another option for contraceptive for women around the world. They all contain the chemical drospirenone, a supposedly safe alternative to the active...
- Jamie G. Goldstein | May 13, 2010 12:21 PM | Chicago, IL
Category:
Miscellaneous
This past Mother’s Day marked another important milestone, the 50th anniversary of the advent of the birth control pill that revolutionized women’s reproductive rights. Today, over 100...